___________________________________________________________________________________________________
“
You miss every shot you don’ t take.”
Marc Joiner does not treat that as just a slogan. It shapes his decisions and guides his career. Today, it forms the foundation of his work as Co-founder at Pete Pharma, where he leads pharmaceutical compounding in a new direction.
He does not operate in a settled market. He is helping pharmacies rethink how personalized medicines are manufactured, moving from labor-intensive manual processes to digitally controlled pharmaceutical compounding. Change like this requires boldness, not caution.“ You just got to go and do it. Just go do it,” Marc says.
From field to pharma
Marc started his career as an internal auditor, but not for long.“ It was very rigid. I was not really into it,” Marc remembers. The structure did not hold his interest, so he moved into sales and soon entered pharmaceutical compounding. There, the environment felt completely different. It was more independent, with decisions made closer to the work and outcomes tied directly to how things got done. Marc joined Medisca and spent his days directly inside compounding pharmacies, not behind a desk. He built his territory by working directly with pharmacists who produced customized medications. That experience shaped his view on adoption: ideas only matter when they work in real-world situations.
With over a decade of working with compounding pharmacies across North America, Marc launched another innovated novel technology that fundamentally changed
Pete Pharma
pharmacy workflows globally. That experience gave him a front-row seat to both the opportunities and inefficiencies within traditional compounding
▲ Marc Joiner americanhealthcareleader. com 81